Zan­tac man­u­fac­tur­ers off the hook af­ter judge dis­miss­es neg­li­gence and fail­ure-to-warn claims in class-ac­tion law­suit

A US Dis­trict Court judge in south­ern Flori­da has dis­missed claims against store-brand and gener­ic man­u­fac­tur­ers of the block­buster heart­burn med­i­cine Zan­tac, which has been re­called over the past cou­ple years due to a po­ten­tial­ly can­cer-caus­ing sub­stance.

In an amend­ed mas­ter per­son­al in­jury com­plaint, thou­sands of peo­ple who say they’ve de­vel­oped var­i­ous can­cers af­ter tak­ing Zan­tac or ran­i­ti­dine prod­ucts (the ac­tive in­gre­di­ent) ac­cused the man­u­fac­tur­ers of 17 counts and a mul­ti­tude of state-spe­cif­ic sub-counts — in­clud­ing neg­li­gence and fail­ure to warn through the FDA.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER